Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alumis Inc. - Common Stock
(NQ:
ALMS
)
10.32
-0.03 (-0.29%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
57,930
Open
10.44
Bid (Size)
4.900 (1)
Ask (Size)
11.99 (12)
Prev. Close
10.35
Today's Range
10.09 - 10.44
52wk Range
9.540 - 13.53
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Jim Cramer Says He's Buying 'Some Target,' But Dismisses SoundHound AI As 'Meme Stock'
October 09, 2024
Target (TGT) stock recommended by Jim Cramer at current price with plans to buy more. Merck (MRK) and Unity Software (U) also discussed.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Alumis to Participate in Upcoming September Investor Conferences
September 03, 2024
From
Alumis Inc.
Via
GlobeNewswire
Performance
YTD
-22.41%
-22.41%
1 Month
-6.61%
-6.61%
3 Month
-8.59%
-8.59%
6 Month
-22.41%
-22.41%
1 Year
-22.41%
-22.41%
More News
Read More
ALMS Stock Earnings: Alumis Reported Results for Q2 2024
August 15, 2024
Via
InvestorPlace
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
August 13, 2024
From
Alumis Inc.
Via
GlobeNewswire
Alumis Initiates ONWARD Phase 3 Clinical Program Evaluating ESK-001, an Oral TYK2 Inhibitor, in Moderate-to-Severe Plaque Psoriasis
July 29, 2024
From
Alumis Inc.
Via
GlobeNewswire
Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation
July 24, 2024
Via
Benzinga
Ardent Health Slips After Downsized IPO
July 21, 2024
Via
Talk Markets
Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering
June 28, 2024
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.